Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether concurrent chemotherapy and IMRT is
effective in the treatment of locally stage T3/T4 recurrent nasopharyngeal carcinoma patients
compared with IMRT alone.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Affiliated TongJi hospital of HuaZhong University of science and Technology First Hospital of FoShan City Fujian Province Tumor Hospital GuiZhou Province Tumor Hospital Hainan Cancer Hospital HaiNan Province Tumor Hospital Hunan Province Tumor Hospital JiangXi Province Tumor Hospital Second Affiliated Hospital of Nanchang University SiChuan Province Tumor Hospital Tongji Hospital Wuhan University YuNan Province Tumor Hospital